Ignite Creation Date:
2024-05-06 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05129605
Status:
RECRUITING
Last Update Posted:
2023-12-08
First Post:
2021-11-02
Brief Title:
Prostate Cancer Genetic Risk Evaluation and Screening Study
Sponsor:
Organization:
Massachusetts General Hospital
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
20 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Saliva blood and urine on all subjects
Tumor tissue on subjects who develop prostate cancer
Enrollment Count:
200
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 80529 |
Who Masked List: